Concern for Tech Ventures over Government grant cut-back
Many Government grant and cash awards for new science and tech ventures have been removed. This includes those for biomedical catalyst and Smart awards for small- and medium-sized enterprises.
An article published in The Oxford Times on 24th March 2016 raised some concern over this recent occurrence in funding. Marks Evans, a member of the Venturefest Management Board commented that this is “pretty strange, when you think where our future economic growth is going to come from”.
Mr Evans is the Chief Executive Officer of Adaptix, a high-tech firm developing low-cost, small-scale high-resolution 3D imaging for the medical tech market and played a key role in our recent Pitchfest events which gives start-ups an opportunity to pitch to investors.
He also noted that “if we want British ingenuity to boost our economy, why cut back on crucial funding?”
For these and other views on the funding cuts, visit the Oxford Times website.
A transfer of knowledge to industry is a good thing: One purpose of a university is to benefit society by disseminating knowledge, and one way this can be done is by commercialising research. Universities and research institutions are a dynamo for entrepreneurship, and for innovation in large companies. READ MORE
When it comes to the commercial success of a technology-led product, there are a number of factors that come into play along the development journey. Have the regulatory requirements been met? Can the design be produced at a viable cost? Is it possible to ensure the quality of the manufacturing process? The list goes on. READ MORE
Microfluidics is a key technology enabling the development of rapid in-vitro diagnostics (IVD). With applications including COVID-19 testing, cardiac arrest assessment and STD screening, decentralised rapid diagnostics are shaping up to be a major part of the future of healthcare and wellness monitoring. READ MORE